Oric Pharmaceuticals (ORIC) Stock Chart & Stock Price History $10.23 -0.26 (-2.48%) Closing price 06/25/2025 04:00 PM EasternExtended Trading$10.26 +0.03 (+0.29%) As of 06/25/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Oric Pharmaceuticals Stock Price Performance The Oric Pharmaceuticals (ORIC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 54.30%, with a year-to-date return of 26.77%. In the past month, the stock has increased 61.10%, reflecting recent market activity. As of the latest close, Oric Pharmaceuticals traded at $10.23 with a market cap of $871.80 million and volume of 793,903 shares. Five years ago, the stock traded at $38.12, representing a 73.16% decrease over that period. At the time, it had a market cap of $1.05 billion and a volume of 290,300 shares. Receive ORIC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+9.88%1 Month Performance+61.10%3 Month Performance+74.87%Year-To-Date Performance+26.77%1 Year Performance+54.30%5 Year Performance-73.16% ORIC Stock Chart for Thursday, June, 26, 2025 ORIC Chart by TradingView Oric Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/25/2025$10.49$10.23-2.48%$10.87$10.20793,903 shs$871.80 million06/24/2025$10.00$10.49+4.90%$10.99$10.341.16 million shs$894 million06/23/2025$9.31$10.00+7.41%$10.01$9.10814,185 shs$852.20 million06/20/2025$9.22$9.31+0.98%$9.50$8.991.57 million shs$793.40 million06/19/2025$9.22$9.22$9.54$8.85749,051 shs$785.77 million06/18/2025$9.03$9.22+2.10%$9.54$8.85749,051 shs$785.73 million06/17/2025$9.41$9.03-4.04%$9.51$9.00808,361 shs$769.57 million06/16/2025$9.63$9.41-2.28%$9.80$9.191.01 million shs$801.96 million06/13/2025$9.67$9.63-0.41%$9.75$9.25714,124 shs$684.58 million06/12/2025$9.39$9.67+2.98%$10.00$9.03814,754 shs$687.42 million Get the Latest News and Ratings for ORIC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/11/2025$9.75$9.39-3.69%$10.04$9.35773,771 shs$667.52 million06/10/2025$9.86$9.75-1.12%$10.00$9.561.04 million shs$693.11 million06/09/2025$9.32$9.86+5.79%$10.00$8.961.17 million shs$700.93 million06/06/2025$9.16$9.32+1.75%$10.07$9.241.38 million shs$662.54 million06/05/2025$9.08$9.16+0.88%$9.46$8.851.48 million shs$651.17 million06/04/2025$8.40$9.08+8.10%$9.09$8.162.14 million shs$645.48 million06/03/2025$8.47$8.40-0.83%$8.75$8.031.23 million shs$597.14 million06/02/2025$8.26$8.47+2.54%$9.48$8.153.13 million shs$602.12 million05/30/2025$7.97$8.26+3.64%$8.40$7.463.62 million shs$587.19 million05/29/2025$5.97$7.97+33.50%$8.44$6.8914.45 million shs$566.57 million05/28/2025$5.78$5.97+3.29%$6.06$5.512.05 million shs$424.40 million05/27/2025$6.35$5.78-8.98%$6.53$5.701.17 million shs$410.89 million05/26/2025$6.35$6.35$6.45$5.80911,637 shs$451.41 million Related Companies Scholar Rock Stock Chart Kymera Therapeutics Stock Chart Viking Therapeutics Stock Chart HUTCHMED Stock Chart Crinetics Pharmaceuticals Stock Chart Catalyst Pharmaceuticals Stock Chart MorphoSys Stock Chart Metsera Stock Chart Alvotech Stock Chart Ascentage Pharma Group International Stock Chart Receive ORIC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oric Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORIC) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTop Picks for Trump’s Pro-Crypto America27 of crypto's most successful minds are about to pull back the curtain… Bitcoin has crushed its all-time h...Crypto 101 Media | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
